| Revision as of 01:21, 19 August 2011 editRubinbot (talk | contribs)43,100 editsm r2.5.4) (robot Adding: ru:Ауротиопрол← Previous edit |
Latest revision as of 12:08, 25 March 2024 edit undoDMacks (talk | contribs)Edit filter managers, Autopatrolled, Administrators186,468 edits auto mw |
| (22 intermediate revisions by 19 users not shown) |
| Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{Drugbox |
|
{{Drugbox |
|
|
| Watchedfields = changed |
|
| verifiedrevid = 443407949 |
|
| verifiedrevid = 445595278 |
|
| IUPAC_name = Sodium aurothiopropanolsulfonate |
|
| IUPAC_name = Sodium aurothiopropanolsulfonate |
|
| image = Aurotioprol.svg |
|
| image = Aurotioprol.svg |
| ⚫ |
| CAS_number = |
|
|
|
|
| ⚫ |
| ATC_prefix = M01 |
|
|
|
<!--Clinical data--> |
| ⚫ |
| ATC_suffix = CB05 |
|
|
|
| tradename = |
|
|
| Drugs.com = {{drugs.com|international|aurotioprol}} |
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
⚫ |
| pregnancy_category = |
|
⚫ |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
⚫ |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
⚫ |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = ] |
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
⚫ |
| bioavailability = |
|
⚫ |
| protein_bound = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
|
|
|
|
<!--Identifiers--> |
|
|
| CAS_number_Ref = {{cascite|correct|CAS}} |
|
⚫ |
| CAS_number = 27279-43-2 |
|
⚫ |
| ATC_prefix = M01 |
|
⚫ |
| ATC_suffix = CB05 |
|
⚫ |
| PubChem = 44144564 |
|
⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
⚫ |
| DrugBank = |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII = G7097J63E9 |
|
| UNII = G7097J63E9 |
|
|
| ChemSpiderID = 8628381 |
| ⚫ |
| PubChem = 44144564 |
|
|
|
|
| ⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
|
|
<!--Chemical data--> |
| ⚫ |
| DrugBank = |
|
|
| chemical_formula = |C=3|H=6|Au=1|Na=1|O=4|S=2| |
|
| chemical_formula = |
|
|
| C=3 | H=6 | Au=1 | Na=1 | O=4 | S=2 |
|
⚫ |
| smiles = C(C(CS(=O)(=O))O).. |
|
| molecular_weight = 390.16 |
|
|
|
| StdInChI = 1S/C3H8O4S2.Au.Na/c4-3(1-8)2-9(5,6)7;;/h3-4,8H,1-2H2,(H,5,6,7);;/q;2*+1/p-2 |
| ⚫ |
| smiles = C(C(CS(=O)(=O))O).. |
|
|
|
| StdInChIKey = KBWWFTIQBJUOQR-UHFFFAOYSA-L |
| ⚫ |
| bioavailability = |
|
| ⚫ |
| protein_bound = |
|
| ⚫ |
| metabolism = |
|
| ⚫ |
| elimination_half-life = |
|
| ⚫ |
| excretion = |
|
| ⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
| ⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
| ⚫ |
| pregnancy_category= |
|
| ⚫ |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| ⚫ |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| ⚫ |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
| ⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
| ⚫ |
| legal_status = |
|
| ⚫ |
| routes_of_administration = ] |
|
|
}} |
|
}} |
|
|
'''Aurotioprol''' is a ] used as an ] agent.<ref>{{cite journal | vauthors = Perrier P, Raffoux C, Thomas P, Tamisier JN, Busson M, Gaucher A, Streiff F | title = HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis | journal = Annals of the Rheumatic Diseases | volume = 44 | issue = 9 | pages = 621–4 | date = September 1985 | pmid = 3876081 | pmc = 1001721 | doi = 10.1136/ard.44.9.621 }}</ref><ref>{{cite journal | vauthors = Veys EM, Mielants H, Verbruggen G | title = Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study | journal = Clinical and Experimental Rheumatology | volume = 5 | issue = 2 | pages = 111–6 | year = 1987 | pmid = 3608266 }}</ref> |
|
{{Unreferenced|date=December 2008}}'''Aurotioprol''' is an ] agent. |
|
|
|
|
|
|
== References == |
|
|
{{Reflist}} |
|
|
|
|
|
{{Antirheumatic products}} |
|
{{Antirheumatic products}} |
|
{{Gold compounds}} |
|
{{Gold compounds}} |
|
|
|
|
|
] |
|
] |
|
] |
|
] |
|
|
] |
|
|
|
|
|
|
|
|
{{musculoskeletal-drug-stub}} |
|
{{musculoskeletal-drug-stub}} |
|
|
|
|
] |
|